Study guide

11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway

NBCRNA CRNA Certified Registered Nurse Anesthetist NCE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology

1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders

2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems

2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms

3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives

3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology

4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics

4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics

5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies

5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout

6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators

6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging

7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation

7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways

8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety

8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety

9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation

9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication

10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring

10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies

11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms

11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)

12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA

12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm

13 Chapter 13: Regional Anesthesia: Neuraxial Blocks

13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma

14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance

14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols

15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice

15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives

16 Chapter 16: Obstetric & Gynecologic Anesthesia

16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient

17 Chapter 17: Pediatric Anesthesia

17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm

18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia

18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols

19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia

19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction

20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia

20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation

21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology

21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements

22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology

22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices

23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures

23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases

24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control

24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure

25 Chapter 25: Neurosurgical Subspecialty Procedures

25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy

26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia

26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery

27 Chapter 27: Orthopedic & Extremity Anesthesia

27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block

28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy

28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia

29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients

29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient

11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway

Key Takeaways Explain This Topic AI

The updated ASA Difficult Airway Algorithm establishes two distinct major decision branches: the Anticipated Difficult Airway (where preservation of spontaneous ventilation with an Awake Intubation strategy is the gold standard) and the Unanticipated Difficult Airway (triggered after induction of general anesthesia).

Awake intubation is strictly indicated in patients with severe stridor, dynamic upper airway tumors, Ludwig's angina, unstable cervical spine injuries, severe micrognathia, or a documented prior history of impossible mask ventilation/intubation.

Pharmacologic preparation for awake intubation requires an antisialagogue (glycopyrrolate 0.2 mg IV 15–30 min prior), continuous high-flow nasal oxygen (apneic oxygenation), targeted airway nerve blocks (glossopharyngeal, superior laryngeal, transtracheal), and careful cooperative sedation using dexmedetomidine or remifentanil without suppressing spontaneous ventilation.

In the unanticipated difficult intubation pathway, attempts at direct or video laryngoscopy must be strictly limited to ≤3 attempts (plus 1 attempt by an experienced colleague); each attempt must include an optimization maneuver (positioning, blade change, bougie, operator change).

Second-generation supraglottic airways (SGAs) with gastric drainage ports provide both an immediate rescue ventilation bridge and an effective conduit for flexible fiberoptic-guided tracheal intubation.

Last updated: August 2026

11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway

The American Society of Anesthesiologists (ASA) Difficult Airway Algorithm provides an evidence-based clinical roadmap to prevent catastrophic perioperative airway morbidity. The updated guidelines emphasize early cognitive recognition, continuous oxygenation (including high-flow nasal cannula/apneic oxygenation), strictly limiting intubation attempts, early integration of video laryngoscopy, rapid deployment of second-generation supraglottic airways (SGAs), and declaring explicit transition points to the emergency pathway.

1. Core Principles & Decision Architecture of the ASA Algorithm

The ASA algorithm is structured around fundamental pre-induction and post-induction decision trees: +-------------------------------------------------------------------------+

  • | ASA DIFFICULT AIRWAY DECISION ARCHITECTURE |
  • +-------------------------------------------------------------------------+
  • | 1. Pre-Induction Evaluation: Is difficulty anticipated? |
  • | --> YES: Proceed to AWAKE INTUBATION Pathway (Spontaneous breathing) |
  • | --> NO: Proceed to Induction of General Anesthesia |
  • | 2. Post-Induction: Unanticipated Difficult Intubation |
  • | --> Attempt Limit: <= 3 attempts (optimize each attempt) |
  • | 3. Post-Induction Branches: |
  • | --> Non-Emergency Pathway: Ventilation ADEQUATE (Face mask or SGA) |
  • | --> Emergency Pathway: Ventilation INADEQUATE ("Cannot Oxygenate") |
  • +-------------------------------------------------------------------------+
  • Universal Guideline Mandates

Continuous Supplemental Oxygen: Deliver continuous oxygen throughout the entire airway management process (preoxygenation, during laryngoscopy via high-flow nasal cannula / apnoeic oxygenation at 10 − 15 L/min 10-15\text{ L/min} 10 − 15 L/min , and throughout extubation).

Limit Intubation Attempts: Strictly limit laryngoscopy/intubation attempts to ≤ 3 \le 3 ≤ 3 attempts (with a single additional attempt permitted only by an experienced colleague, absolute maximum 4). Repeated blade insertions produce mucosal bleeding, progressive supraglottic edema, laryngospasm, and convert a "can ventilate" scenario into a lethal "Cannot Intubate, Cannot Oxygenate" (CICO) crisis.

Optimize Every Attempt: Never repeat an attempt under identical conditions. Modify at least one variable per attempt:

Position: Sniffing position, ramped position (ear-to-sternal notch alignment), or head elevation.

Device/Blade: Switch from Macintosh to Miller, or direct laryngoscopy to hyperangulated video laryngoscope (e.g., GlideScope, McGrath, C-MAC D-blade).

Adjunct: Introduce a coude gum elastic bougie or rigid stylet.

External Manipulation: Apply Optimal External Laryngeal Manipulation (OELM) or BURP maneuver (Backward, Upward, Rightward Pressure on thyroid cartilage).

Operator: Hand off to the most experienced airway provider.

2. Anticipated Difficult Airway: The Awake Intubation Pathway

When a comprehensive preoperative assessment predicts severe difficulty with intubation, mask ventilation, or supraglottic airway placement, Awake Intubation with preservation of spontaneous ventilation is the safest clinical approach.

Clinical Indications for Awake Intubation

Upper Airway Pathology / Stridor: Supraglottic tumor, laryngeal papilloma, severe subglottic stenosis, vocal cord masses.

Infectious Airway Distortion: Ludwig's angina (submandibular cellulitis), retropharyngeal abscess, peritonsillar abscess with severe trismus.

Unstable Cervical Spine: Traumatic cervical fracture, severe atlantoaxial subluxation in rheumatoid arthritis, severe ankylosing spondylitis (where head extension is impossible or neurologically hazardous).

Craniofacial Anomalies: Severe micrognathia, retrognathia, Pierre Robin sequence, Treacher Collins syndrome, restricted mouth opening ( < 1.5 − 2.0 cm <1.5-2.0\text{ cm} < 1.5 − 2.0 cm ).

Prior Airway Catastrophe: Documented history of failed intubation, emergency surgical airway, or CICO. +-------------------------------------------------------------------------+

  • | AWAKE INTUBATION PREPARATION CHECKLIST |
  • +-------------------+-----------------------------+-----------------------+
  • | 1. Drying Agent | 2. Topicalization & Blocks | 3. Conscious Sedation |
  • | - Glycopyrrolate | - Lidocaine 4% nebulizer | - Dexmedetomidine |
  • | 0.2 mg IV | - Glossopharyngeal block | - Remifentanil TCI |
  • | (15-30m prior) | - Superior laryngeal block | - Maintain airway |
  • | - Prevents saliva | - Transtracheal RLN block | reflexes & drive |
  • +-------------------+-----------------------------+-----------------------+
  • 3. Pharmacology & Airway Nerve Blocks for Awake Intubation

Successful awake intubation requires adequate mucosal anesthesia and suppression of gag and cough reflexes while preserving spontaneous alveolar ventilation and patient cooperativeness.

1. Pre-Procedure Drying Agent (Antisialagogue)

Glycopyrrolate (Robinul) 0.2 mg 0.2\text{ mg} 0.2 mg IV / IM administered 15 − 30 minutes 15-30\text{ minutes} 15 − 30 minutes prior to topicalization.

Mechanism & Rationale: Quaternary ammonium anticholinergic that does not cross the blood-brain barrier (eliminates risk of central anticholinergic syndrome and confusion). Drying secretions is vital because saliva dilutes local anesthetics and obscures the optical lens of flexible fiberoptic bronchoscopes.

2. Topical Anesthesia & Toxicity Thresholds

4% Lidocaine Nebulization: 4 mL 4\text{ mL} 4 mL ( 160 mg 160\text{ mg} 160 mg ) delivered via high-flow oxygen nebulizer over 15 minutes anesthetizes the nasal cavity, oropharynx, and vocal cords.

2% Viscous Lidocaine Gargle / 5% Lidocaine Ointment: Anesthetizes the anterior two-thirds of the tongue and hard/soft palates.

Local Anesthetic Systemic Toxicity (LAST) Limit: Maximum safe plain lidocaine mucosal dose is 4.5 mg/kg 4.5\text{ mg/kg} 4.5 mg/kg (or ≈ 300 − 400 mg \approx 300-400\text{ mg} ≈ 300 − 400 mg total in adults). Rapid systemic absorption across hypervascular pharyngeal mucosa produces blood levels approaching direct intravenous injection.

3. Targeted Airway Nerve Blocks SENSORY INNERVATION OF THE AIRWAY

  • Structure Nerve Supply Block Technique
  • ---------------------------------------------------------------------------------
  • Nose / Nasopharynx --> Trigeminal (CN V1 / V2) --> 4% Cocaine / Oxymetazoline
  • Post. 1/3 Tongue --> Glossopharyngeal (CN IX) --> Tonsillar Pillar Infiltration
  • Epiglottis (Ventral) --> Glossopharyngeal (CN IX) -->
  • Epiglottis (Dorsal) --> Superior Laryngeal (CN X - Int.) --> Greater Cornu of Hyoid
  • Vocal Cords (Supra) --> Superior Laryngeal (CN X - Int.) -->
  • Vocal Cords (Infra) --> Recurrent Laryngeal (CN X) --> Transtracheal Membrane Stab
  • Trachea / Subglottis --> Recurrent Laryngeal (CN X) -->

Nerve Block Target Anatomy & Innervation Territory Needle Landmarks & Injection Technique Potential Complications / Pearls

Glossopharyngeal Nerve Block (CN IX) Sensory to posterior 1/3 of tongue, vallecula, anterior epiglottis, tonsillar pillars, pharyngeal wall (eliminates gag reflex ) Patient opens mouth widely; tongue retracted medially. 22–25G needle inserted 0.5 cm 0.5\text{ cm} 0.5 cm deep at the base of the palatoglossal arch (posterior tonsillar pillar) bilaterally. Aspirate, then inject 2 mL 2\text{ mL} 2 mL of 2% lidocaine per side. Internal Carotid Artery Puncture: The internal carotid artery lies immediately posterior to the tonsillar pillar. Strict aspiration before injection is mandatory. Toxic seizures occur with accidental intra-arterial injection.

Superior Laryngeal Nerve (SLN) Block (Internal Branch - CN X) Sensory to larynx above the vocal cords (dorsal epiglottis, aryepiglottic folds, arytenoids, false vocal cords) Palpate the greater cornu of the hyoid bone and thyroid notch. Insert a 25G needle walking off the inferior border of the greater cornu toward the thyrohyoid membrane . Inject 2 mL 2\text{ mL} 2 mL of 2% lidocaine bilaterally ( 1 mL 1\text{ mL} 1 mL superficial, 1 mL 1\text{ mL} 1 mL deep to thyrohyoid membrane). Puncture of the internal branch of the SLN or superior laryngeal artery; hematoma formation. Internal SLN is purely sensory (external branch is motor to cricothyroid muscle).

Recurrent Laryngeal Nerve (RLN) Block / Transtracheal Injection (CN X) Sensory to larynx below the vocal cords and upper trachea (eliminates cough reflex ) Identify the cricothyroid membrane in the midline. Insert a 20–22G needle or angiocatheter attached to a syringe with 3 − 4 mL 3-4\text{ mL} 3 − 4 mL of 4% lidocaine. Advance perpendicular while aspirating. Once free air bubbles are aspirated (confirming tracheal lumen entry), rapidly inject the lidocaine at end-expiration . Patient will cough forcefully , atomizing the lidocaine upward across the undersurface of the vocal cords. Avoid direct bilateral RLN motor block, which causes bilateral cord paralysis and total upper airway obstruction.

4. Sedation Regimens for Awake Intubation

Dexmedetomidine ( α 2 \alpha_2 α 2 ​ -agonist): Loading dose 0.5 − 1.0 μ g/kg 0.5-1.0\ \mu\text{g/kg} 0.5 − 1.0 μ g/kg IV over 10 minutes, followed by infusion of 0.2 − 0.7 μ g/kg/hr 0.2-0.7\ \mu\text{g/kg/hr} 0.2 − 0.7 μ g/kg/hr . Provides "cooperative sedation" (patient easily rousable, follows commands) with zero respiratory depression and intrinsic antisialagogue properties.

Remifentanil Target-Controlled Infusion (TCI): 1.0 − 2.5 ng/mL 1.0-2.5\text{ ng/mL} 1.0 − 2.5 ng/mL effect-site concentration (or 0.05 − 0.15 μ g/kg/min 0.05-0.15\ \mu\text{g/kg/min} 0.05 − 0.15 μ g/kg/min ) provides potent cough suppression while preserving spontaneous respiratory drive.

Avoid Heavy Benzodiazepine / Opioid Boluses: Midazolam and fentanyl boluses frequently cause sudden upper airway collapse, hypoxemia, and loss of cooperation in a partially anesthetized airway.

4. Unanticipated Difficult Airway: Stepwise Management

When unexpected difficulty arises following the induction of general anesthesia and neuromuscular blockade, the provider must execute a disciplined, rapid sequence of rescue maneuvers. +-------------------------------------------------------------------------+

  • | STEPWISE UNANTICIPATED DIFFICULT INTUBATION RESCUE |
  • +-------------------------------------------------------------------------+
  • | 1. CALL FOR HELP & ANNOUNCE ATTEMPT NUMBER |
  • | 2. Direct/Video Laryngoscopy Attempt 1: Standard view / reposition |
  • | 3. Attempt 2: Switch to Hyperangulated VL + Bougie / Change operator |
  • | 4. Attempt 3: Final optimized attempt (Total <= 3 attempts) |
  • | 5. Declare INTUBATION FAILURE --> Transition to RESCUE VENTILATION |
  • | --> Face Mask Ventilation OR Second-Generation SGA |
  • +-------------------------------------------------------------------------+
  • The Non-Emergency Pathway (Ventilation Adequate)

If tracheal intubation has failed after ≤ 3 \le 3 ≤ 3 attempts, but bag-mask ventilation or SGA ventilation maintains oxygenation ( S p O 2 ≥ 90 % SpO_2 \ge 90\% Sp O 2 ​ ≥ 90% on 100 % O 2 100\%\ O_2 100% O 2 ​ , continuous E t C O 2 EtCO_2 EtC O 2 ​ waveform present), the provider is in the Non-Emergency Pathway . +-------------------------------------------------------------------------+

  • | NON-EMERGENCY PATHWAY OPTIONS |
  • +-------------------------------------------------------------------------+
  • | Option A: AWAKEN THE PATIENT (Safest strategy for elective surgery) |
  • | Option B: Video Laryngoscope or Fiberoptic Intubation via SGA Conduit |
  • | Option C: Proceed with surgery using SGA (Low aspiration risk only) |
  • | Option D: Elective surgical tracheostomy |
  • +-------------------------------------------------------------------------+
  • Second-Generation SGAs as Intubation Conduits

Second-generation SGAs (e.g., Ambu AuraGain, LMA Fastrach, i-gel, LMA Protector) feature:

High Seal Pressures ( > 30 cm H 2 O >30\text{ cm H}_2\text{O} > 30 cm H 2 ​ O ): Protects against gastric insufflation.

Gastric Drainage Lumen: Allows suctioning and decompression of stomach contents.

Direct Line-of-Sight Airway Channel: Accommodates a flexible fiberoptic bronchoscope preloaded with an uncuffed or cuffed ETT ( 6.0 − 7.0 mm 6.0-7.0\text{ mm} 6.0 − 7.0 mm ) to achieve fiberoptic-guided intubation while maintaining continuous ventilation.

5. Video Laryngoscopy (VL) Mechanics & Optical Strategies

Video laryngoscopy has revolutionized airway management and is recommended as an initial or early rescue device in the ASA guidelines. +-------------------------------------------------------------------------+

  • | STANDARD VS. HYPERANGULATED VL BLADES |
  • +--------------------------------+----------------------------------------+
  • | Standard Geometry (Macintosh) | Hyperangulated Blade (GlideScope/D-Bl) |
  • | - Curved 20-30 degrees | - Acute 60 degree anterior curve |
  • | - Line-of-sight & screen view | - Looks "around the corner" (no sight) |
  • | - Standard malleable stylet | - Requires RIGID 60-90° PREFORMED STYLET
  • | - Displaces tongue base | - Does NOT require line-of-sight align |
  • +--------------------------------+----------------------------------------+
  • Hyperangulated Blade Intubation: The 3-Step Rule

Because a hyperangulated blade looks around the curvature of the tongue without aligning the oral, pharyngeal, and laryngeal axes, viewing the glottis is easy, but directing the tube into the trachea can be challenging.

Step 1 (Direct Vision): Look into the patient's mouth while inserting the blade and advancing the rigid styletted ETT until the tip enters the posterior oropharynx.

Step 2 (Screen Vision): Look up at the monitor. Manipulate the blade to center the glottis in the upper third of the screen; advance the ETT tip through the vocal cords.

Step 3 (Disengagement): Once the cuff passes the vocal cords, withdraw the rigid stylet 3 − 5 cm 3-5\text{ cm} 3 − 5 cm to soften the tube and prevent anterior tracheal wall trauma, then advance the tube to the correct depth under video guidance.

Loading diagram... ASA Difficult Airway Algorithm: Anticipated and Unanticipated Pathways